Severe cutaneous necrosis in antiphospholipid syndrome

被引：0
|
作者：
Mostafa, Mariam [1 ,4 ]
Mahmoud, Amir [1 ]
Egiza, Hebat-Allah [2 ]
Niu, Chengu [1 ]
Elbahnasawy, Mohamed [1 ]
Yusuf, Yasmin [3 ]
Kouides, Peter [1 ]
机构：
[1] Rochester Gen Hosp, Rochester, NY USA
[2] Egypt Japan Univ Sci & Technol, Alexandria, Egypt
[3] Kaleida Hlth, Buffalo, NY USA
[4] 1425 Portland Ave, Rochester, NY 14621 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 11期
关键词：
RECURRENT THROMBOSIS; MANIFESTATIONS; RITUXIMAB; THERAPY; PREVENTION; WARFARIN; TRIAL; APS;
D O I：
10.1002/ajh.27067
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E328 / E333
页数：6
相关论文
共 50 条
  • [1] Antiphospholipid syndrome
    Danowski, Adriana
    Levy, Roger A.
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2013, 53 (02) : 139 - 140
  • [2] Cutaneous necrosis in patient with antiphospholipid syndrome successfully treated with topical pimecrolimus and warfarin
    Bianchi, Leonardo
    Sensini, Chiara
    Hansel, Katharina
    Tramontana, Marta
    Romita, Paolo
    Giuffrida, Roberta
    Stingeni, Luca
    DERMATOLOGIC THERAPY, 2020, 33 (04)
  • [3] Pituitary necrosis and antiphospholipid syndrome
    Khochtali, I.
    Kacem, M.
    Kria, S.
    Golli, M.
    Mahjoub, S.
    ANNALES D ENDOCRINOLOGIE, 2009, 70 (02) : 126 - 128
  • [4] Severe Symptomatic Stenosis of Visceral and Renal Arteries Leading Primary Antiphospholipid Syndrome Diagnosis
    Salaun, Erwan
    Bartoli, Michel Alain
    Soler, Raphael
    Khibri, Hajar
    Ebbo, Mickael
    Bernit, Emmanuelle
    Flavian, Antonin
    Harle, Jean Robert
    Magnan, Pierre Edouard
    Sarlon-Bartoli, Gabrielle
    ANNALS OF VASCULAR SURGERY, 2014, 28 (07) : 1796.e9 - 1796.e13
  • [5] Progression of antiphospholipid antibody syndrome to catastrophic antiphospholipid antibody syndrome acutely with cessation of antithrombotic therapy
    Katikireddi, V. S.
    Kandiah, D. A.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (05) : 585 - 591
  • [6] Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial
    Pengo, V.
    Banzato, A.
    Bison, E.
    Zoppellaro, G.
    Jose, S. Padayattil
    Denas, G.
    LUPUS, 2016, 25 (03) : 301 - 306
  • [7] Antiphospholipid syndrome, antiphospholipid antibodies, and stroke
    Mittal, Prabal
    Quattrocchi, Graziella
    Tohidi-Esfahani, Ibrahim
    Sayar, Zara
    Chandratheva, Arvind
    Cohen, Hannah
    INTERNATIONAL JOURNAL OF STROKE, 2023, 18 (04) : 383 - 391
  • [8] Secondary prevention in thrombotic antiphospholipid syndrome
    Pengo, V.
    Denas, G.
    Banzato, A.
    Bison, E.
    Bracco, A.
    Facchinetti, M.
    Hoxha, A.
    Ruffatti, A.
    LUPUS, 2012, 21 (07) : 734 - 735
  • [9] Should bleeding be a concern in antiphospholipid syndrome?
    Orsi, Fernanda A.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (01)
  • [10] An update on current management strategies for antiphospholipid syndrome-related thrombosis
    Rossi, Andrea
    Colorio, Cecilia
    Puente, Dolores
    Forastiero, Ricardo
    CLINICAL LIPIDOLOGY, 2014, 9 (01) : 91 - 100
12345